Onderneming CV Sciences, Inc. Other OTC
Aandelen
CVSI
US1266541028
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Herb-based Supplements and Hemp-based Cannabidiol
100,0
%
| 16 | 100,0 % | 16 | 100,0 % | -1,24% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 16 | 100,0 % | 16 | 100,0 % | -1,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16-06-14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26-12-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16-06-14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21-07-22 |
William McCorkle
BRD | Director/Board Member | 56 | 21-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 163 228 469 | 163 197 469 ( 99,98 %) | 0 | 99,98 % |
Aandeel B | 0 | 1 000 | 0 | 0 |
Bedrijfsgegevens
CV Sciences, Inc.
9530 Padgett Street Suite 107
92126, San Diego
+866 290 2157
http://www.cvsciences.com![Adres CV Sciences, Inc.(CVSI)](https://cdn.zonebourse.com/static/address/28607904.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,93% | 803 mld. | |
+41,27% | 631 mld. | |
-7,08% | 351 mld. | |
+17,40% | 324 mld. | |
+10,58% | 303 mld. | |
+16,75% | 243 mld. | |
+2,13% | 228 mld. | |
+10,23% | 217 mld. | |
+6,24% | 164 mld. |